Rani Therapeutics Holdings RANI
NASDAQ RANI
$0.60 +0.02 (+2.83%)
As of: Oct 23, 2026 · 2:17 PM EDT

Rani Therapeutics Holdings (RANI) Amortization of Deferred Charges (2022 - 2025)

Updated

Analysis

Rani Therapeutics Holdings (RANI) Amortization of Deferred Charges (2022 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,127.42 Bn 1,096.00 Bn 19.71 Bn
2 Johnson & Johnson 633.77 Bn 553.63 Bn 17.30 Bn
3 AbbVie 505.19 Bn 478.30 Bn 12.70 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn
5 Novartis Ag 290.00 Bn 253.99 Bn 11.24 Bn
6 Astrazeneca 265.19 Bn 238.88 Bn 12.86 Bn
7 Amgen 238.02 Bn 193.42 Bn 7.24 Bn
8 Gilead Sciences 194.79 Bn 168.99 Bn 6.22 Bn
9 Pfizer 171.11 Bn 117.76 Bn 10.94 Bn
10 Rani Therapeutics Holdings 112.43 Mn -7.13 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 33,000.00
Sep 30, 2025 58,000.00
Jun 30, 2025 58,000.00
Mar 31, 2025 58,000.00
Dec 31, 2024 58,000.00
Sep 30, 2024 58,000.00
Jun 30, 2024 58,000.00
Mar 31, 2024 58,000.00
Dec 31, 2023 58,000.00
Sep 30, 2023 58,000.00
Jun 30, 2023 58,000.00
Mar 31, 2023 58,000.00
Dec 31, 2022 58,000.00
Sep 30, 2022 19,000.00
API Access

Rani Therapeutics Holdings Amortization of Deferred Charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortization-of-deferred-charges&ticker=RANI&period=max&api_key=YOUR_API_KEY